Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma. - Archive ouverte HAL Access content directly
Journal Articles Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics Year : 2009

Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.

(1) , (1) , (2) , (1) , (3) , (3) , (4) , (1)
1
2
3
4

Abstract

Aberrant methylation of tumor suppressor gene promoters has been extensively investigated in cervical cancer. Transcriptional silencing, as a main consequence of hypermethylation of CpG islands, is the predominant mechanism of p16(INK4a) and E-cadherin gene inactivation in malignant epithelial tumors. This study was conducted to evaluate the promoter methylation status of p16(INK4a) and E-cadherin genes in 22 specimens of cervical carcinomas, four cervical cancer cell lines (HeLa, SiHa, Caski, C33A), and 20 human papillomavirus negative specimens, obtained from normal cervical swabs, using the methylation-specific PCR approach. Hypermethylation of the 5' CpG island of the p16(INK4a) and E-cadherin genes were found in 13 (59.1%) and 10 (45.5%) of 22 cervical cancer samples, respectively. Furthermore, our findings did not show any correlation between promoter methylation of p16(INK4a) and E-cadherin genes and clinicopathological parameters, including HPV infection, phenotypic distribution, and stage of the disease. However, hypermethylation of E-cadherin gene promoter appears to be age related in cervical cancer, whereas the frequency of aberrant methylation of p16(INK4a) gene promoter is unchanged according to the age of patients. Thus, caution must be made to use these markers in the diagnosis of cervical cancer. However, dietary or pharmaceutical agents that can inhibit these epigenetic events may prevent or delay the development of cervical cancer.
Fichier principal
Vignette du fichier
p16_methylation_CC.pdf (216.25 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-00641556 , version 1 (16-11-2011)

Identifiers

  • HAL Id : pasteur-00641556 , version 1
  • PUBMED : 20112504

Cite

Mohammed Attaleb, Wail El Hamadani, Meriem Khyatti, Laila Benbacer, Nadia Benchekroun, et al.. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.. Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics, 2009, 18 (4), pp.185-92. ⟨pasteur-00641556⟩

Collections

RIIP RIIP_MAROC
119 View
785 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More